Guardian Pharmacy Extends Revolving Credit Facility and Flexibility
Memorial Day Sale – Claim 70% Off TipRanks
- Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
- Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
An announcement from Guardian Pharmacy Services, Inc. Class A ( (GRDN) ) is now available.
On May 21, 2026, Guardian Pharmacy Services, Inc. and certain subsidiaries executed an eighth amendment to their existing loan and security agreement with Regions Bank and other lenders, updating the documentation to name the public company as borrower and extending the maturity of the revolving credit facility from April 23, 2027 to May 21, 2030. The amendment allows the company to add up to $40 million in incremental term loans or revolver increases, potentially lifting total borrowing capacity to $80 million, raises certain basket and threshold limits, and replaces a consolidated leverage ratio covenant with a consolidated net leverage ratio covenant that nets up to $20 million of unrestricted cash against debt, changes that collectively provide greater financial flexibility and recalibrate covenant metrics for stakeholders.
The most recent analyst rating on (GRDN) stock is a Buy with a $43.00 price target. To see the full list of analyst forecasts on Guardian Pharmacy Services, Inc. Class A stock, see the GRDN Stock Forecast page.
Spark’s Take on GRDN Stock
According to Spark, TipRanks’ AI Analyst, GRDN is a Neutral.
The score is driven primarily by improved financial performance (rapid growth, profitability rebound, strong balance sheet, positive free cash flow). Offsetting factors include a demanding valuation and mixed near-term technical momentum, while the latest earnings call was net positive but highlighted IRA-related pricing and working-capital volatility plus ongoing margin/cost headwinds.
To see Spark’s full report on GRDN stock, click here.
More about Guardian Pharmacy Services, Inc. Class A
Guardian Pharmacy Services, Inc. operates in the pharmacy services industry, providing medication management and related services, likely with a focus on long-term care and institutional pharmacy solutions. The company functions as a public borrower in the credit markets, utilizing secured loan facilities to support its operations and growth initiatives within its specialized healthcare niche.
Average Trading Volume: 479,868
Technical Sentiment Signal: Buy
Current Market Cap: $2.44B
See more insights into GRDN stock on TipRanks’ Stock Analysis page.
